Cel Sci (CVM) Common Equity (2010 - 2026)
Cel Sci's Common Equity came in at $10.96 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 56.0% from $7.02 million a year earlier and up 59.4% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cel Sci's Common Equity was $15.96 million, up 24.0% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -4.2% (FY2020 to FY2025).
- Going back by fiscal year, Common Equity was $12.87 million in FY2024 (-2.6%), $13.21 million in FY2023 (-58.9%), $32.16 million in FY2022 (-43.1%) and $56.53 million in FY2021 (+186.6%).
- The five-year range for quarterly Common Equity is $6.87 million (fiscal Q2 2026) to $56.53 million (fiscal Q4 2021).
- Year-over-year, Common Equity increased in two of the last eight quarters, with an average decline of 1.2%.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2021 (growth of 186.6%), and the weakest in fiscal Q3 2023 (a decline of 61.8%).
- Business Quant data shows CVM's Common Equity at $6.87 million (Q2 2026), $11.14 million (Q1 2026) and $15.96 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Cel Sci | 58.11 Mn | 32.46 Mn | - | 10.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.96 Mn |
| Mar 31, 2026 | 6.87 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Sep 30, 2025 | 15.96 Mn |
| Jun 30, 2025 | 7.02 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 11.31 Mn |
| Sep 30, 2024 | 12.87 Mn |
| Jun 30, 2024 | 8.47 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 12.65 Mn |
| Sep 30, 2023 | 13.21 Mn |
| Jun 30, 2023 | 14.79 Mn |
| Mar 31, 2023 | 20.15 Mn |
| Dec 31, 2022 | 26.59 Mn |
| Sep 30, 2022 | 32.16 Mn |
| Jun 30, 2022 | 38.73 Mn |
| Mar 31, 2022 | 45.13 Mn |
| Dec 31, 2021 | 51.35 Mn |
| Sep 30, 2021 | 56.53 Mn |
API Access
Cel Sci Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();